The Effect of Bee Venom Peptides Melittin, Tertiapin, and Apamin on the Human Erythrocytes Ghosts: A Preliminary Study.

apamin bee venom peptides erythrocytes ghosts proteome hemolytic activity human erythrocytes melittin tertiapin

Journal

Metabolites
ISSN: 2218-1989
Titre abrégé: Metabolites
Pays: Switzerland
ID NLM: 101578790

Informations de publication

Date de publication:
13 May 2020
Historique:
received: 11 04 2020
revised: 05 05 2020
accepted: 11 05 2020
entrez: 17 5 2020
pubmed: 18 5 2020
medline: 18 5 2020
Statut: epublish

Résumé

Red blood cells (RBCs) are the most abundant cells in the human blood that have been extensively studied under morphology, ultrastructure, biochemical and molecular functions. Therefore, RBCs are excellent cell models in the study of biologically active compounds like drugs and toxins on the structure and function of the cell membrane. The aim of the present study was to explore erythrocyte ghost's proteome to identify changes occurring under the influence of three bee venom peptides-melittin, tertiapin, and apamin. We conducted preliminary experiments on the erythrocyte ghosts incubated with these peptides at their non-hemolytic concentrations. Such preparations were analyzed using liquid chromatography coupled with tandem mass spectrometry. It was found that when higher concentrations of melittin and apamin were used, fewer proteins were identified. Moreover, the results clearly indicated that apamin demonstrates the greatest influence on the RBCs ghosts proteome. Interestingly, the data also suggest that tertiapin exerted a stabilizing effect on the erythrocyte membrane. The experiments carried out show the great potential of proteomic research in the projects focused on the toxin's properties as membrane active agents. However, to determine the specificity of the effect of selected bee venom peptides on the erythrocyte ghosts, further proteomic research should be focused on the quantitative analysis.

Identifiants

pubmed: 32413967
pii: metabo10050191
doi: 10.3390/metabo10050191
pmc: PMC7281017
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Narodowe Centrum Nauki
ID : 2016/23/D/NZ7/03949

Références

J Clin Invest. 1989 Jul;84(1):7-17
pubmed: 2738160
Blood. 2008 Nov 15;112(10):3939-48
pubmed: 18988878
Blood Transfus. 2011 Jul;9(3):274-7
pubmed: 21251470
Nat Protoc. 2013 Aug;8(8):1551-66
pubmed: 23868073
Cereb Cortex. 2020 Mar 21;30(2):563-574
pubmed: 31188425
Toxins (Basel). 2019 Aug 27;11(9):
pubmed: 31461888
Blood Cells Mol Dis. 2012 Jun 15;49(1):1-10
pubmed: 22465511
PLoS One. 2013 Apr 18;8(4):e61700
pubmed: 23637888
Front Pharmacol. 2017 Jun 28;8:412
pubmed: 28701955
J Pharmacol Exp Ther. 2000 Apr;293(1):196-205
pubmed: 10734170
J Pharm Biomed Anal. 2016 Mar 20;121:69-76
pubmed: 26780156
Neurosci Lett. 2005 Sep 23;386(1):5-8
pubmed: 15985330
Sci Rep. 2017 Aug 24;7(1):9306
pubmed: 28839153
Mol Membr Biol. 2003 Jul-Sep;20(3):255-9
pubmed: 12893533
Oxid Med Cell Longev. 2018 Nov 8;2018:6375379
pubmed: 30533175
Clin Chem. 2007 May;53(5):852-8
pubmed: 17395711
Cell. 2014 Dec 4;159(6):1389-403
pubmed: 25467444
J Proteome Res. 2017 Aug 4;16(8):2752-2761
pubmed: 28689405
Free Radic Res. 2018 Jun;52(6):724-736
pubmed: 29669446
J Cell Biol. 1983 Mar;96(3):730-5
pubmed: 6833381
J Mass Spectrom. 2015 May;50(5):766-70
pubmed: 26259660
Int J Mol Sci. 2018 Jul 31;19(8):
pubmed: 30065196
Eur J Biochem. 1979 Mar;94(2):355-64
pubmed: 428392
Br J Pharmacol. 2000 Oct;131(3):569-77
pubmed: 11015309
Behav Brain Res. 2013 Jan 15;237:71-5
pubmed: 22983217
Cancer Res. 2009 Feb 15;69(4):1293-301
pubmed: 19176383
Front Mol Neurosci. 2018 Jul 30;11:258
pubmed: 30104956
Biosci Rep. 2007 Oct;27(4-5):189-223
pubmed: 17139559
Molecules. 2016 May 11;21(5):
pubmed: 27187328
Transfus Clin Biol. 2010 Sep;17(3):151-64
pubmed: 20655788
Int J Neurosci. 2011 Apr;121(4):209-17
pubmed: 21265705
Arch Biochem Biophys. 1963 Jan;100:119-30
pubmed: 14028302
J Biol Chem. 2006 Sep 15;281(37):27398-404
pubmed: 16844690
EMBO J. 2000 Aug 1;19(15):3896-904
pubmed: 10921872
Toxins (Basel). 2013 Apr 17;5(4):637-64
pubmed: 23594437
J Biochem. 2016 May;159(5):481-90
pubmed: 26684586
Clin Proteomics. 2018 Mar 21;15:14
pubmed: 29588628
Environ Toxicol Pharmacol. 2013 Sep;36(2):697-705
pubmed: 23892471
Annu Rev Immunol. 1989;7:35-58
pubmed: 2469439
Blood. 2016 Jan 14;127(2):187-99
pubmed: 26537302
J Neurosci. 2002 Dec 1;22(23):10163-71
pubmed: 12451117
Blood. 2006 Aug 1;108(3):791-801
pubmed: 16861337
J Proteomics. 2012 Dec 5;76 Spec No.:194-202
pubmed: 22954596
Biochem Biophys Res Commun. 1988 Dec 30;157(3):1117-23
pubmed: 2849930
Bioorg Khim. 1983 Jan;9(1):26-32
pubmed: 6091685
Toxins (Basel). 2015 Apr 01;7(4):1126-50
pubmed: 25835385

Auteurs

Agata Światły-Błaszkiewicz (A)

Department of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, 60-780 Poznan, Poland.

Lucyna Mrówczyńska (L)

Department of Cell Biology, Faculty of Biology, Adam Mickiewicz University in Poznan, 61-614 Poznan, Poland.

Eliza Matuszewska (E)

Department of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, 60-780 Poznan, Poland.

Jan Lubawy (J)

Department of Animal Physiology and Development, Faculty of Biology, Adam Mickiewicz University in Poznan, 61-614 Poznan, Poland.

Arkadiusz Urbański (A)

Department of Animal Physiology and Development, Faculty of Biology, Adam Mickiewicz University in Poznan, 61-614 Poznan, Poland.

Zenon J Kokot (ZJ)

Department of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, 60-780 Poznan, Poland.

Grzegorz Rosiński (G)

Department of Animal Physiology and Development, Faculty of Biology, Adam Mickiewicz University in Poznan, 61-614 Poznan, Poland.

Jan Matysiak (J)

Department of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, 60-780 Poznan, Poland.

Classifications MeSH